Our Advice

Our company understands how frustrating and illogical the stock market can be. We have been involved in stock markets for 40 years and had success despite these shortcomings. Through our missives, quarterly newsletters and appearances in the media, we provide advice on how to play the long game. 

Search

AI Boom Reaches the Grid

A mania associated with electric production companies providing electricity to technology enterprises pursuing Artificial Intelligence (AI) agendas looks familiar. An announcement this week by Meta that they signed a deal with Constellation Energy (CEG) and the corresponding surge in the share price of CEG rang a big bell in our minds. Our regular readers will be reminded that a few weeks after the 2024 US presidential election, we made the case that we were in the stock market at the polar opposite of the late-1980 euphoria over President Ronald Reagan's victory. Stocks were massively under-owned in 1980, interest rates were sky high, and inflation had run rampant. [...]

⟶ Keep Reading

Private Market Values in Energy

The investors of Smead Capital Management believe, which we count ourselves among, that energy stock valuations in the stock market have become too depressed. Mr. Market gets scared, as he does from time to time. This can go on for a while, but we have seen a couple of private transactions in two different parts of North America energy markets that explain how attractive the pricing is for the assets that Mr. Market could own. [...]

⟶ Keep Reading

Just Say No to Drugs

[...] Thanks to pressure from the new Trump administration, the pharmaceutical stocks look somewhat as deeply out of favor relative to the S&P 500 Index as they were in 1994. For political reasons, the new administration is looking to bring inflation down. The persistent inflation from the massive $12 trillion of U.S. Treasury borrowing done to get us through COVID-19 seemed to doom any reelection possibilities for President Biden. Therefore, President Trump wants to get Republican candidates elected in the midterm elections. To him, driving down drug prices (and oil prices) is the way to gain favor with voters. [...]

⟶ Keep Reading

Our Advice

AllMissivesPressQuarterly NewslettersRadio InterviewsTV Appearances

In the Money Podcast: Cole Smead, CFA on Canadian Oil Stocks and How the Market is Dead Wrong

June 12, 2025

In the Money with Amber Kanwar Cole Smead: The Market Is Dead Wrong on Canadian Oil Stocks | In the Money with Amber Kanwar     Stocks mentioned: SCR.TO, CVE.TO, […]

⟶ Keep Reading

Bloomberg Open Interest: Cole Smead, CFA on Oil, Homebuilders and the Future of Berkshire

June 10, 2025

Open Interest 6/10/2025 By Matt Miller, Katie Greifeld and Sonali Basak For more information go to www.bloomberg.com. Stocks mentioned: BRK The information contained in this article represents SCM’s opinions, and […]

⟶ Keep Reading

AI Boom Reaches the Grid

June 5, 2025

A mania associated with electric production companies providing electricity to technology enterprises pursuing Artificial Intelligence (AI) agendas looks familiar. An announcement this week by Meta that they signed a deal with Constellation Energy...

⟶ Keep Reading

Investment News: Cole Smead, CFA on Homebuilders and Energy

June 4, 2025

Don’t count out value stocks, says Smead Capital CEO For more information go to www.investmentnews.com. The information contained in this article represents SCM’s opinions, and should not be construed as […]

⟶ Keep Reading

Yahoo Finance: Cole Smead, CFA on the US Deficit

May 30, 2025

  US deficit is an ‘economic stabilizer’ amid uncertainty  For more information go to finance.yahoo.com. The information contained in this tv appearance represents SCM’s opinions, and should not be construed […]

⟶ Keep Reading

Private Market Values in Energy

May 29, 2025

The investors of Smead Capital Management believe, which we count ourselves among, that energy stock valuations in the stock market have become too depressed. Mr. Market gets scared, as he does from time...

⟶ Keep Reading

Just Say No to Drugs

May 22, 2025

[...] Thanks to pressure from the new Trump administration, the pharmaceutical stocks look somewhat as deeply out of favor relative to the S&P 500 Index as they were in 1994. For political reasons,...

⟶ Keep Reading

Bloomberg: Bill Smead on Target’s Current Leadership

May 21, 2025

Target CEO Under Pressure as Boycott, Tariffs Hit Sales By Jaewon Kang For more information go to www.bloomberg.com. Stock mentioned: TGT The information contained in this article represents SCM’s opinions, […]

⟶ Keep Reading

We Advise Investors

Sign up to get our advice sent straight to your inbox.

Scroll to Top